Compounds > sch 39370
Page last updated: 2024-09-03

sch 39370 and bradykinin

sch 39370 has been researched along with bradykinin in 5 studies

Compound Research Comparison

Studies
(sch 39370)		Trials
(sch 39370)		Recent Studies (post-2010)
(sch 39370)		Studies
(bradykinin)		Trials
(bradykinin)		Recent Studies (post-2010) (bradykinin)
251014,1953551,520

Protein Interaction Comparison

ProteinTaxonomysch 39370 (IC50)bradykinin (IC50)
B2 bradykinin receptorHomo sapiens (human)0.0018

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiu, PJ; Sybertz, EJ; Vemulapalli, S; Watkins, RW1
Boublik, JH; Evans, RG; Lakat, L; Lew, RA; Pipolo, LA; Smith, AI; Tomoda, F1
Evans, RG; Lew, RA; Madden, AC; Smith, AI; Tomoda, F1
Chappell, MC; Ferrario, CM; Iyer, SN1
Kokkonen, JO; Kovanen, PT; Kuoppala, A; Lindstedt, KA; Saarinen, J1

Other Studies

5 other study(ies) available for sch 39370 and bradykinin

ArticleYear
Neutral metalloendopeptidase inhibition: a novel means of circulatory modulation.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1990, Volume: 8, Issue:7

    Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Desoxycorticosterone; Dioxolanes; Dipeptides; Hypertension; Male; Methionine; Neprilysin; Rats; Rats, Inbred Strains; Sodium, Dietary

1990
Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
    British journal of pharmacology, 1996, Volume: 118, Issue:5

    Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Dipeptides; Dose-Response Relationship, Drug; Glycopeptides; Gonadotropin-Releasing Hormone; In Vitro Techniques; Kidney; Metalloendopeptidases; Protease Inhibitors; Rabbits; Rats; Stereoisomerism; Vasoconstrictor Agents

1996
Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    British journal of pharmacology, 1996, Volume: 119, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Consciousness; Dipeptides; Enzyme Inhibitors; Heart Rate; Kidney; Metalloendopeptidases; Neprilysin; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Rabbits; Receptors, Bradykinin

1996
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
    Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:1 Pt 2

    Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dipeptides; Heart Rate; Hypertension; Kinetics; Lisinopril; Losartan; Male; Neprilysin; Organophosphonates; Peptide Fragments; Peptides, Cyclic; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Renin-Angiotensin System

1998
Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
    Circulation, 1999, Apr-20, Volume: 99, Issue:15

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Bradykinin; Captopril; CD13 Antigens; Dipeptides; Female; Glycopeptides; Heart Failure; Humans; Kallidin; Leucine; Male; Membrane Proteins; Middle Aged; Myocardium; Neprilysin; Peptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Substrate Specificity

1999